By expenditures
| Name | Title | Type |
|---|---|---|
| Christopher Turtell | Partner | Auditee |
| Brian Feick | Business Administrator | Auditee |
| Linda S. Himeback | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 352972 | 2023 | 2025-04-08 | Herbein and Company | $3.91M |
| 315563 | 2022 | 2024-07-22 | Herbein + Company INC | $6.08M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 352972 | 2023 | 2025-04-08 | 1130806 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 1130805 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 1130804 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 1130803 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 1130802 | 2023-006 | Significant Deficiency | - | L |
| 352972 | 2023 | 2025-04-08 | 1130801 | 2023-005 | Significant Deficiency | - | AB |
| 352972 | 2023 | 2025-04-08 | 1130800 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 1130799 | 2023-006 | Significant Deficiency | - | L |
| 352972 | 2023 | 2025-04-08 | 1130798 | 2023-005 | Significant Deficiency | - | AB |
| 352972 | 2023 | 2025-04-08 | 554364 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 554363 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 554362 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 554361 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 554360 | 2023-006 | Significant Deficiency | - | L |
| 352972 | 2023 | 2025-04-08 | 554359 | 2023-005 | Significant Deficiency | - | AB |
| 352972 | 2023 | 2025-04-08 | 554358 | 2023-007 | Significant Deficiency | Yes | P |
| 352972 | 2023 | 2025-04-08 | 554357 | 2023-006 | Significant Deficiency | - | L |
| 352972 | 2023 | 2025-04-08 | 554356 | 2023-005 | Significant Deficiency | - | AB |
| 315563 | 2022 | 2024-07-22 | 1055495 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 1055494 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 1055493 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 1055492 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 1055491 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 1055490 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 1055489 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 1055488 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 1055487 | 2022-002 | Material Weakness | - | AB |
| 315563 | 2022 | 2024-07-22 | 1055486 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 1055485 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 1055484 | 2022-002 | Material Weakness | - | AB |
| 315563 | 2022 | 2024-07-22 | 1055483 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 1055482 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 1055481 | 2022-002 | Material Weakness | - | AB |
| 315563 | 2022 | 2024-07-22 | 1055480 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 1055479 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 1055478 | 2022-002 | Material Weakness | - | AB |
| 315563 | 2022 | 2024-07-22 | 479053 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 479052 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 479051 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 479050 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 479049 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 479048 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 479047 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 479046 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 479045 | 2022-002 | Material Weakness | - | AB |
| 315563 | 2022 | 2024-07-22 | 479044 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 479043 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 479042 | 2022-002 | Material Weakness | - | AB |
| 315563 | 2022 | 2024-07-22 | 479041 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 479040 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 479039 | 2022-002 | Material Weakness | - | AB |
| 315563 | 2022 | 2024-07-22 | 479038 | 2022-004 | Significant Deficiency | - | L |
| 315563 | 2022 | 2024-07-22 | 479037 | 2022-003 | Significant Deficiency | - | P |
| 315563 | 2022 | 2024-07-22 | 479036 | 2022-002 | Material Weakness | - | AB |